These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 33940026)
1. Novel Chitosan-Coated Niosomal Formulation for Improved Management of Bacterial Conjunctivitis: A Highly Permeable and Efficient Ocular Nanocarrier for Azithromycin. Eid HM; Naguib IA; Alsantali RI; Alsalahat I; Hegazy AM J Pharm Sci; 2021 Aug; 110(8):3027-3036. PubMed ID: 33940026 [TBL] [Abstract][Full Text] [Related]
2. Encapsulation of Azithromycin Ion Pair in Liposome for Enhancing Ocular Delivery and Therapeutic Efficacy on Dry Eye. Ren T; Lin X; Zhang Q; You D; Liu X; Tao X; Gou J; Zhang Y; Yin T; He H; Tang X Mol Pharm; 2018 Nov; 15(11):4862-4871. PubMed ID: 30251864 [TBL] [Abstract][Full Text] [Related]
3. Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and Chitosan Coating. Eid HM; Elkomy MH; El Menshawe SF; Salem HF AAPS PharmSciTech; 2019 May; 20(5):183. PubMed ID: 31054011 [TBL] [Abstract][Full Text] [Related]
4. Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate. Tan G; Yu S; Pan H; Li J; Liu D; Yuan K; Yang X; Pan W Int J Biol Macromol; 2017 Jan; 94(Pt A):355-363. PubMed ID: 27760378 [TBL] [Abstract][Full Text] [Related]
5. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment. Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274 [TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107 [TBL] [Abstract][Full Text] [Related]
9. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783 [TBL] [Abstract][Full Text] [Related]
10. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity. Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505 [TBL] [Abstract][Full Text] [Related]
11. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study. Zaid Alkilani A; Hamed R; Abdo H; Swellmeen L; Basheer HA; Wahdan W; Abu Kwiak AD ACS Omega; 2022 Nov; 7(44):39782-39793. PubMed ID: 36385887 [TBL] [Abstract][Full Text] [Related]
12. Contribution of anti-inflammatory and anti-virulence effects of azithromycin in the treatment of experimental Staphylococcus aureus keratitis. Ikemoto K; Kobayashi S; Haranosono Y; Kozai S; Wada T; Tokushige H; Kawamura A BMC Ophthalmol; 2020 Mar; 20(1):89. PubMed ID: 32143675 [TBL] [Abstract][Full Text] [Related]
13. Intranasal Niosomal In Situ Gel As A Novel Strategy for Improving Citicoline Efficacy and Brain Delivery in Treatment of Epilepsy: In Vitro and Ex Vivo Characterization and In Vivo Pharmacodynamics Investigation. Bekhet MA; Ali AA; Kharshoum RM; El-Ela FIA; Salem HF J Pharm Sci; 2022 Aug; 111(8):2258-2269. PubMed ID: 35235845 [TBL] [Abstract][Full Text] [Related]
14. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery. Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726 [TBL] [Abstract][Full Text] [Related]
15. Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine. Khalifa AM; Abdul Rasool BK AAPS PharmSciTech; 2017 Nov; 18(8):3064-3075. PubMed ID: 28516414 [TBL] [Abstract][Full Text] [Related]
16. Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures. Tulbah AS; Elkomy MH; Zaki RM; Eid HM; Eissa EM; Ali AA; Yassin HA; Aldosari BN; Naguib IA; Hassan AH Int J Pharm X; 2023 Dec; 6():100206. PubMed ID: 37637477 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. He W; Guo X; Feng M; Mao N Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of optimized zolmitriptan niosomal emulgel. Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700 [No Abstract] [Full Text] [Related]
19. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery. Shinde UA; Joshi PN; Jain DD; Singh K Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402 [TBL] [Abstract][Full Text] [Related]
20. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation. Soliman OAE; Mohamed EA; Khatera NAA Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]